Coenzyme Q10

Statins can cause muscle symptoms, and muscle symptoms are the leading reason people stop taking a drug that was protecting their heart. rs4149056 in SLCO1B1 is the variant behind part of that — it affects how much statin reaches the liver rather than staying in the blood, and it is the one place in this subject where a genotype has real prescribing guidance behind it. See statin-associated muscle symptoms.

Coenzyme Q10 is what gets sold to those people. The reasoning: statins block a pathway that also produces CoQ10, CoQ10 is needed by mitochondria, muscles are full of mitochondria, so replacing it should help.

The trials disagree, and they have disagreed for twenty years. A 2025 meta-analysis of seven randomised trials in 389 patients found a significant reduction in muscle pain overall — a weighted mean difference of −0.96 (95% CI −1.88 to −0.03) — with four of the seven trials positive and three showing no change. That confidence interval nearly touches zero, and the authors said in so many words that more research is needed before evidence-based recommendations can be made.

The more awkward result is a 2022 trial that went and measured the mechanism. Thirty-seven people on simvastatin took 400 mg of CoQ10 or placebo for eight weeks, with muscle biopsies. CoQ10 in muscle did not rise. Mitochondrial respiratory capacity did not change. Myalgia did not improve, and individual changes in muscle CoQ10 did not track changes in pain.

So the honest position is the one this page is filed under: unsettled, leaning towards the story being better than the evidence. If the muscle symptoms are real enough that you are considering stopping a statin, the conversation worth having is with the prescriber — about the dose, the drug, and whether SLCO1B1 is relevant to you — rather than with a bottle.